Haifa, Israel

Noa Sher

This inventor holds 7 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Minovia Therapeutics Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noa Sher. Retrieved from https://idiyas.com/inventor/noa-sher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Noa Sher in Mitochondrial Augmentation Therapy

Introduction

Noa Sher is an accomplished inventor based in Haifa, Israel. He has made significant contributions to the field of mitochondrial augmentation therapy, focusing on treatments for brain and renal diseases. With a total of 7 patents to his name, Sher is at the forefront of innovative medical solutions.

Latest Patents

Noa Sher's latest patents include groundbreaking inventions aimed at enhancing the treatment of various diseases. One of his notable patents is for "Mitochondrial augmentation therapy of brain diseases." This invention provides stem cells enriched with healthy functional mitochondria, along with pharmaceutical compositions and methods for treating brain diseases, disorders, and symptoms associated with acquired mitochondrial dysfunction. Another significant patent is for "Mitochondrial augmentation therapy of renal diseases," which similarly offers stem cells enriched with healthy mitochondria for treating renal diseases and disorders.

Career Highlights

Noa Sher is currently associated with Minovia Therapeutics Ltd., a company dedicated to advancing mitochondrial therapies. His work has been instrumental in developing innovative treatments that address critical health issues related to mitochondrial dysfunction.

Collaborations

Noa collaborates with talented individuals in his field, including Natalie Yivgi Ohana and Uriel Halavee. Their combined expertise contributes to the advancement of mitochondrial therapies and the development of effective treatment options.

Conclusion

Noa Sher's contributions to mitochondrial augmentation therapy represent a significant advancement in medical science. His innovative patents and collaborations are paving the way for new treatments that could improve the quality of life for patients suffering from various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…